Volume 29, Number 8—August 2023
Dispatch
Emerging Corynebacterium diphtheriae Species Complex Infections, Réunion Island, France, 2015–2020
Table 2
Patient no. | Isolate | Year | Isolation site | Species | Biovar | tox gene | Elek test | ST† | Co-infections‡ |
---|---|---|---|---|---|---|---|---|---|
1 |
CD1/FRC0304 | 2015 | Cutaneous | C. diphtheriae | Gravis | Negative | NA | 102 | S. pyogenes, S. aureus, A. haemolyticum |
CD2/FRC0316 |
2015 |
Respiratory |
C. diphtheriae |
Mitis |
Negative |
NA |
95 |
S. aureus |
|
2 |
CD3/FRC0314 |
2015 |
Cutaneous |
C. diphtheriae |
Mitis |
Positive |
Positive |
421 |
S. aureus |
3 |
CD4/FRC0376 |
2015 |
Cutaneous |
C. diphtheriae |
Gravis |
Positive |
Positive |
388 |
S. pyogenes |
4 |
CD5/FRC0383 | 2016 | Cutaneous | C. diphtheriae | Mitis | Negative | NA | 423 | S. pyogenes, S. aureus |
CD6/FRC0393 |
2016 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
423 |
S. pyogenes, S. aureus |
|
5 |
CD7/FRC0385 |
2016 |
Cutaneous |
C. diphtheriae |
Mitis |
Positive |
Positive |
91 |
S. pyogenes |
6 |
CU1/FRC0391 |
2016 |
Cutaneous |
C. ulcerans |
NA |
Negative |
NA |
339 |
S. dysgalactiae |
7 |
CD8/FRC0402 |
2016 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
410 |
S. dysgalactiae |
8 |
CD9/FRC0410 |
2016 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
415 |
S. pyogenes |
9 |
CD10/FRC0423 |
2016 |
Cutaneous |
C. diphtheriae |
Gravis |
Negative |
NA |
101 |
S. aureus |
10 |
CD11/FRC0477 |
2017 |
Cutaneous |
C. diphtheriae |
Gravis |
Negative |
NA |
481 |
S. pyogenes, S. aureus, A. haemolyticum |
11 |
CD12/FRC0501 |
2017 |
Cutaneous |
C. diphtheriae |
Gravis |
Positive |
Positive |
521 |
S. pyogenes |
12 |
CD13/FRC0624 |
2018 |
Bone |
C. diphtheriae |
Mitis |
Negative |
NA |
237 |
S. aureus |
13 |
CD14/FRC0630 |
2018 |
Cutaneous |
C. diphtheriae |
Gravis |
Negative |
NA |
606 |
S. pyogenes, S. aureus |
14 |
CD15/FRC0733 |
2019 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
351 |
S. pyogenes |
15 |
CD16/FRC0782 | 2019 | Cutaneous | C. diphtheriae | Mitis | Positive | Positive | 688 | S. pyogenes, S. aureus |
CD17/FRC0809 |
2019 |
Cutaneous |
C. diphtheriae |
Mitis |
Positive |
Positive |
688 |
S. aureus |
|
16 |
CD18/FRC0819 |
2019 |
Cutaneous |
C. diphtheriae |
Gravis |
Positive |
Positive |
87 |
S. pyogenes, A. haemolyticum |
17 |
CU2/FRC0820 |
2019 |
Bone |
C. ulcerans |
NA |
Negative |
NA |
339 |
S. aureus |
18 |
CD19/FRC0849 |
2019 |
Cutaneous |
C. diphtheriae |
Mitis |
Positive |
Positive |
426 |
S. pyogenes, S. aureus |
19 |
CD20/FRC0865 |
2020 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
102 |
S. pyogenes, S. aureus |
20 |
CD21/FRC0875 |
2020 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
707 |
S. pyogenes |
21 |
CD22/FRC0893 |
2020 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
708 |
S. pyogenes |
22 |
CD23/FRC0928 |
2020 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
88 |
S. pyogenes |
23 |
CD24/FRC0970 |
2020 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
88 |
S. pyogenes, S. aureus, A. haemolyticum |
24 |
CD25/FRC0975 |
2020 |
Cutaneous |
C. diphtheriae |
Mitis |
Negative |
NA |
88 |
S. aureus |
25 |
CD26/FRC1050 |
2020 |
Bone |
C. diphtheriae |
Mitis |
Negative |
NA |
771 |
A. haemolyticum |
26 | CD27/FRC1065 | 2020 | Bone | C. diphtheriae | Mitis | Negative | NA | 88 | S. aureus |
*CD, Corynebacterium diphtheriae; CU, C. ulcerans; NA, not applicable; ST, sequence type. †Numbers in bold indicate a common ST shared among strains from different patients. ‡Co-infections with Arcanobacterium haemolyticum, Staphylococcus aureus, Streptococcus dysgalactiae, or Streptococcus pyogenes.
1These first authors contributed equally to this article.
2These authors contributed equally to this article.
Page created: May 31, 2023
Page updated: July 25, 2023
Page reviewed: July 25, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.